My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

467.71 -2.04 (-0.43%)
Streaming Delayed Price Updated: 12:16 PM EDT, Sep 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
28 29 Next >
Thermo Fisher Scientific (TMO) Q3 2022 Earnings Call Transcript
TMO earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Big Tech Misses
Good Morning Everyone! Remember, the bigger the drawdown the better bigger the bounce. 
Via Benzinga
Thermo Fisher Q3 Earnings Beat Street View, With 14% Organic Sales Growth
 
Via Benzinga
Thermo Fisher Scientific: Q3 Earnings Insights
Thermo Fisher Scientific (NYSE:TMO) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Thermo Fisher Scientific Reports Third Quarter 2022 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Thermo Fisher Invests $160M to Expand Bioproduction Capacity
 
Via Benzinga
Expert Ratings for Thermo Fisher Scientific
Analysts have provided the following ratings for Thermo Fisher Scientific (NYSE:TMO) within the last quarter: 
Via Benzinga
Earnings Scheduled For October 26, 2022
Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion. 
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $8,300 Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 13.25% on an annualized basis producing an average annual return of 23.54%. Currently, Thermo Fisher Scientific... 
Via Benzinga
How Is The Market Feeling About Thermo Fisher Scientific?
Thermo Fisher Scientific's (NYSE:TMO) short percent of float has fallen 7.5% since its last report. The company recently reported that it has 2.88 million shares sold short, which is 0.74% of all... 
Via Benzinga
Bonds And Stocks Slide While Stock Earnings Split
The big headline of today was bonds including TLT and IEF extending their downward slide to fresh new lows of 2022. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Check Out What Whales Are Doing With TMO
A whale with a lot of money to spend has taken a noticeably bullish stance on Thermo Fisher Scientific. Looking at options history for Thermo Fisher Scientific (NYSE:TMO) we detected 10 strange... 
Via Benzinga
Buying These 3 Stocks Could Be the Smartest Move You Ever Make
Look past all the noise and think about the bigger picture. 
Via The Motley Fool
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 20 years by 10.85% on an annualized basis producing an average annual return of 18.23%. Currently, Thermo Fisher Scientific... 
Via Benzinga
Thermo Fisher Scientific Prices Offering of Yen-Denominated Senior Notes
From Thermo Fisher Scientific Inc.
Via Business Wire
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
One analyst doubts any deal could come to fruition. If it did, it would make sense. 
Via Investor's Business Daily
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all. 
Via Benzinga
7 Value Stocks That Are Too Cheap to Ignore
With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy. 
Via InvestorPlace
Check Out What Whales Are Doing With TMO
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher's Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
 
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
 
Via Benzinga
Can Healthcare Stocks Continue To Outperform?
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis. 
Via Talk Markets
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in... 
Via Benzinga
Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of
Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved... 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.